|
References
1. Ageno W, Pransoni P, Romualdi E, et al. The metabolic syndrome and the risk of venous thrombosis: A case controlled study. Journal of Thrombosis and Hemostasis 2006;4:1914-1918.
2. Lecture by Michael Laposata, Hypercoagulability and Thrombosis. Dade Behring, Boston.
3. Alessi MC. Obesity, Metabolic Syndrome and VTE, ISTH, Geneva Switzerland, July 8, 2007.
4. Behan KJ, Mbizo J. The relationship between waist circumference and biomarkers for diabetes and CVD in healthy non-obese women. The Pensacola Study, Labo Medicine 2007;(7):422-427.
5. Movahed MR, Hashemzadeh M, Jamal M.,The prevalence of pulmonary embolism and pulmonary hypertension in patients with type II diabetes mellitus. Chest 2005;3568-3571.
6. Vaidyula VR, Rao AK, Mozzoli M, et al. Effects of hyperglycemia and hyperinsulinemia on circulating tissue factor procoagulant activity and platelet CD40 ligand. Diabetes 2005;55:202-208.
7. Fontbonne A, Chalas MA, Vague IJ, Bard JM, Andre P, et al. The effect of metformin on the metabolic abnormalities associated with upper body fat distribution. Diabetes Care 1996;9:920-926.
8. Kolde HJ. Haemostasis: Physiology, Pathology and Diagnostics. Pentapharm Ltd, Basel/Switzerland, 2nd edition, 2004.
9. Oganova E. Factor von Willebrand in patients with metabolic syndrome (abstract), Byelorussian Medical Academy, Minsk, ISTH, Geneva, July 2007.
|